hCD19
品系全名
C57BL/6JSmo-Cd19tm1(hCD19) Smoc
目录号
NM-HU-00110
品系状态
活体
基因信息
基因名
CD19
品系描述
验证数据

Fig.1 Expression characterization of hCD19 on B cells in blood in hCD19 knockin mice.

Fig.2 Expression characterization of hCD19 on B cells in spleen in hCD19 knockin mice.

Fig.3 Expression characterization of hCD19 on B cells in thymus in hCD19 knockin mice.

Fig.4 Body weight and ratios of spleen, thymus and MLN to body weight of 8-week-old hCD19 knockin mice. (n=6 for all groups, Mean±SEM, Unpaired t-test, *P<0.05, **P<0.01).
Abbr. HO, homozygous; WT, wild type; MLN, mesenteric lymph nodes.

Table 1. Blood routine examination of hCD19 knockin mice. Values are expressed as mean±SEM.
Abbr. HO, homozygous; WT, wild type.

Table 2. Biochemical test of serum from hCD19 knockin mice. Values are expressed as mean±SEM.
Abbr. HO, homozygous; WT, wild type.

Fig.5 Blood biochemical detection of 8-week-old hCD19 knockin mice. (n=6 for all groups, Mean±SEM).
Abbr. HO, homozygous; WT, wild type.

Fig.6 Detection of myeloid cell subsets in the blood of 8-week-old hCD19 knockin mice by FACS (n=3 in all groups).
Abbr. WT, wild type; HO, homozygous.

Fig.7 Detection of lymphocyte subsets in the blood of 8-week-old hCD19 knockin mice by FACS (n=3 in all groups).
Abbr. WT, wild type; HO, homozygous.

Fig.8 Detection of myeloid cell subsets in the spleen of 8-week-old hCD19 knockin mice by FACS (n=3 in all groups).
Abbr. WT, wild type; HO, homozygous.

Fig.9 Detection of lymphocyte subsets in the spleen of 8-week-old hCD19 knockin mice by FACS (n=3 in all groups).
Abbr. WT, wild type; HO, homozygous.

Fig.10 Pathological analysis of hCD19 knockin mice by H&E staining.
There were no obvious pathological changes in these tissues. (n=3, 8-week-old)
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
